Macular Edema Key Players : ActiveSite Pharmaceuticals Inc, Coherus BioSciences Inc, Lupin Ltd, Mabion SA, OMEICOS Therapeutics GmbH, Promedior Inc Market Analysis and Forecast 2017-2021

Macular edema

Overview

Macular edema is swelling or fluid retention in a specialized part of the retina called the macula. Symptoms of macular oedema include blurred or wavy central vision and/or colors appear changed. There are many causes of macular edema. It is frequently associated with diabetes, where damaged blood vessels in the retina begin to leak fluids, including small amounts of blood, into the retina.

Other causes include Macular Edema, side effects of certain medications and certain genetic disorders, such as retinoschisis or retinitis pigments.

Click here for sample report @ https://www.wiseguyreports.com/sample-request/2593469-macular-edema-pipeline-review-h2-2017

Macular Edema Industry Major Highlights:

Macular Edema - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Macular Edema (Ophthalmology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The report further guide in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Macular Edema (Ophthalmology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Major Outlook of Macular Edema Report:

The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

- The pipeline guide reviews key companies involved in Macular Edema (Ophthalmology) therapeutics and enlists all their major and minor projects.

- The pipeline guide evaluates Macular Edema (Ophthalmology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

The pipeline guide provides a snapshot of the global therapeutic landscape of Macular Edema (Ophthalmology).

- The pipeline guide reviews pipeline therapeutics for Macular Edema (Ophthalmology) by companies and universities/research institutes based on information derived from company and industry-specific sources.

Competitive Analysis for Macular Edema

Key players are making innovative developments in Macular Edema industry.  The same will help in improving the market performance. Heavy investments are made by major players in the R&D sector.

The key players in this market are: ActiveSite Pharmaceuticals Inc, Coherus BioSciences Inc, Lupin Ltd, Mabion SA, OMEICOS Therapeutics GmbH, Promedior Inc, Taiwan Liposome Company Ltd and Xbrane Biopharma AB.

….. Continued

Table of Contents

Introduction 5

Global Markets Direct Report Coverage 5

Macular Edema - Overview 6

Macular Edema - Therapeutics Development 7

Pipeline Overview 7

Pipeline by Companies 8

Products under Development by Companies 10

Macular Edema - Therapeutics Assessment 11

Assessment by Target 11

Assessment by Mechanism of Action 13

Assessment by Route of Administration 15

Assessment by Molecule Type 17

Macular Edema - Companies Involved in Therapeutics Development 19

ActiveSite Pharmaceuticals Inc 19

Coherus BioSciences Inc 19

Lupin Ltd 20

Marion SA 20

For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/2593469-macular-edema-pipeline-review-h2-2017

Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs

WISEGUY RESEARCH CONSULTANTS PVT LTD
Office No. 528, Amanora Chambers
Pune - 411028
Maharashtra, India

This release was published on openPR.